BREATH THERAPEUTICS GMBH has a total of 26 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals are MIRA PHARMA CORP, MD BIOLAB CO LTD and UNIV MEDYCZNY W BIAŁYMSTOKU.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | United States | 3 | |
#7 | Brazil | 2 | |
#8 | Colombia | 2 | |
#9 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Denk Oliver | 19 |
#2 | Iacono Aldo | 6 |
#3 | Börner Gerhard | 4 |
#4 | Knoch Martin | 3 |
#5 | Borner Gerhard | 2 |
#6 | Oliver Denk | 2 |
#7 | Mehrwald Ralf | 1 |
#8 | Akkar Aslihan | 1 |
#9 | Boerner Gerhard | 1 |
#10 | Lacono Aldo | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020115032A1 | Inhalable compositions for use in the treatment of pulmonary diseases | |
EP3813862A1 | Inhalable compositions comprising macrocyclic immunosuppressants | |
AU2019295027A1 | Pharmaceutical compositions in lyophilized form | |
BR112020020564A2 | CYCLOSPORIN FORMULATIONS FOR USE IN THE TREATMENT OF BRONCHIOLITE OBLITERANT SYNDROME (BOS) |